BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 14/04/2010

FDA Removes Essential-Use Designations for Certain Inhalers Containing Ozone-Depleting Substances

The FDA is amending its regulation to remove essential-use designations for certain inhalers containing ozone-depleting substances, allowing for the reformulation of these products without releasing ODSs, effective as of a specified date.

Source: Federal Register — Health and Human ServicesOpen original release →